Cargando…
Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer
With the advance in personalized therapeutic strategies in patients with breast cancer, there is an increasing need for biomarker-guided therapy. Although the immunogenicity of breast cancer has not been strongly considered in research or practice, tumor-infiltrating lymphocytes (TILs) are emerging...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579275/ https://www.ncbi.nlm.nih.gov/pubmed/26278518 http://dx.doi.org/10.4132/jptm.2015.07.29 |